Associations of clinical and inflammatory biomarker clusters with juvenile idiopathic arthritis categories.


Journal

Rheumatology (Oxford, England)
ISSN: 1462-0332
Titre abrégé: Rheumatology (Oxford)
Pays: England
ID NLM: 100883501

Informations de publication

Date de publication:
01 05 2020
Historique:
received: 21 02 2019
revised: 30 07 2019
pubmed: 23 4 2020
medline: 29 8 2020
entrez: 23 4 2020
Statut: ppublish

Résumé

To identify discrete clusters comprising clinical features and inflammatory biomarkers in children with JIA and to determine cluster alignment with JIA categories. A Canadian prospective inception cohort comprising 150 children with JIA was evaluated at baseline (visit 1) and after six months (visit 2). Data included clinical manifestations and inflammation-related biomarkers. Probabilistic principal component analysis identified sets of composite variables, or principal components, from 191 original variables. To discern new clinical-biomarker clusters (clusters), Gaussian mixture models were fit to the data. Newly-defined clusters and JIA categories were compared. Agreement between the two was assessed using Kruskal-Wallis analyses and contingency plots. Three principal components recovered 35% (three clusters) and 40% (five clusters) of the variance in patient profiles in visits 1 and 2, respectively. None of the clusters aligned precisely with any of the seven JIA categories but rather spanned multiple categories. Results demonstrated that the newly defined clinical-biomarker lustres are more homogeneous than JIA categories. Applying unsupervised data mining to clinical and inflammatory biomarker data discerns discrete clusters that intersect multiple JIA categories. Results suggest that certain groups of patients within different JIA categories are more aligned pathobiologically than their separate clinical categorizations suggest. Applying data mining analyses to complex datasets can generate insights into JIA pathogenesis and could contribute to biologically based refinements in JIA classification.

Identifiants

pubmed: 32321162
pii: 5570882
doi: 10.1093/rheumatology/kez382
doi:

Substances chimiques

Biomarkers 0
Inflammation Mediators 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1066-1075

Subventions

Organisme : CIHR
Pays : Canada

Informations de copyright

© The Author(s) 2019. Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved. For permissions, please email: journals.permissions@oup.com.

Auteurs

Elham Rezaei (E)

Department of Pediatrics, University of Saskatchewan, Saskatoon, Canada.

Daniel Hogan (D)

Department of Computer Sciences, University of Saskatchewan.

Brett Trost (B)

Department of Computer Sciences, University of Saskatchewan.

Anthony J Kusalik (AJ)

Department of Computer Sciences, University of Saskatchewan.

Gilles Boire (G)

Département de Médecine, Université de Sherbrooke, Sherbrooke.

David A Cabral (DA)

Department of Pediatrics, British Columbia Children's Hospital, Vancouver.

Sarah Campillo (S)

Department of Pediatrics, McGill University Health Center, Montreal.

Gaëlle Chédeville (G)

Department of Pediatrics, McGill University Health Center, Montreal.

Anne-Laure Chetaille (AL)

Département de Médecine le Centre Hospitalier Universitaire de Quebec, Quebec.

Paul Dancey (P)

Department of Pediatrics, Janeway Children's Health and Rehabilitation Centre, St. John's.

Ciaran Duffy (C)

Department of Pediatrics, Children's Hospital of Eastern Ontario, Ottawa.

Karen Watanabe Duffy (KW)

Department of Pediatrics, Children's Hospital of Eastern Ontario, Ottawa.

Simon W M Eng (SWM)

Department of Pediatrics, University of Toronto and the Hospital for Sick Children, Toronto.

John Gordon (J)

Department of Medicine, University of Saskatchewan.

Jaime Guzman (J)

Department of Pediatrics, British Columbia Children's Hospital, Vancouver.

Kristin Houghton (K)

Department of Pediatrics, British Columbia Children's Hospital, Vancouver.

Adam M Huber (AM)

Department of Pediatrics, IWK Health Centre and Dalhousie University, Halifax.

Roman Jurencak (R)

Department of Pediatrics, Children's Hospital of Eastern Ontario, Ottawa.

Bianca Lang (B)

Department of Pediatrics, IWK Health Centre and Dalhousie University, Halifax.

Ronald M Laxer (RM)

Department of Pediatrics, University of Toronto and the Hospital for Sick Children, Toronto.

Kimberly Morishita (K)

Department of Pediatrics, British Columbia Children's Hospital, Vancouver.

Kiem G Oen (KG)

Department of Pediatrics, University of Manitoba, Winnipeg.

Ross E Petty (RE)

Department of Pediatrics, British Columbia Children's Hospital, Vancouver.

Suzanne E Ramsey (SE)

Department of Pediatrics, IWK Health Centre and Dalhousie University, Halifax.

Stephen W Scherer (SW)

The Centre for Applied Genomics, Toronto, Canada.

Rosie Scuccimarri (R)

Department of Pediatrics, McGill University Health Center, Montreal.

Lynn Spiegel (L)

Department of Pediatrics, University of Toronto and the Hospital for Sick Children, Toronto.

Elizabeth Stringer (E)

Department of Pediatrics, IWK Health Centre and Dalhousie University, Halifax.

Regina M Taylor-Gjevre (RM)

Department of Medicine, University of Saskatchewan.

Shirley M L Tse (SML)

Department of Pediatrics, University of Toronto and the Hospital for Sick Children, Toronto.

Lori B Tucker (LB)

Department of Pediatrics, British Columbia Children's Hospital, Vancouver.

Stuart E Turvey (SE)

Department of Pediatrics, British Columbia Children's Hospital, Vancouver.

Susan Tupper (S)

Department of Pediatrics, University of Saskatchewan, Saskatoon, Canada.

Richard F Wintle (RF)

The Centre for Applied Genomics, Toronto, Canada.

Rae S M Yeung (RSM)

Department of Pediatrics, University of Toronto and the Hospital for Sick Children, Toronto.

Alan M Rosenberg (AM)

Department of Pediatrics, University of Saskatchewan, Saskatoon, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH